StockData
Stryker Corp logo

Stryker Corp

SYKNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 19/3024% below fair value
$306.81+14.95 (+5.12%)

Close on Nov 2, 2026Market cap $117.68BP/E 32.7Yield –

Stryker MedSurg & Neurotechnology — U.S. Net Sales by Quarter

MedSurg & Neurotechnology — U.S. Net Sales ($M) ($M)

QuarterlyAnnual

Stryker MedSurg & Neurotechnology — U.S. Net Sales: $2,904M in Q3 2026, up 9.6% from a year earlier.

Latest, Q3 2026
2,904
Period ended Sep 30, 2026
Change on a year earlier
+9.6%
2,650 in Q3 2025
History
18 quarters
Since Q1 2022
Sources
7
Documents cited below

Where the Q3 2026 figure comes from

Reported in Stryker Form 8-K, Form 10-Q Note 15 XBRL & Change-in-Presentation Recast Schedules.

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedMedSurg & Neurotechnology — U.S. Net Sales ($M) ($M)Year on yearSource
Q3 2026Sep 30, 20262,904+9.6%0000310764-26-000059|sykex991earningsq32026.htm ↗
Q2 2026Jun 30, 20262,854+8.7%0000310764-26-000048|sykex991earningsq22026.htm ↗
Q1 2026Mar 31, 20262,494+3.2%Stryker Form 10-Q — FY2026Q1 (filed 2026-05-11) ↗
Q4 2025Dec 31, 20253,122+16.5%ir|change_in_pres_2026Q1 ↗
Q3 2025Sep 30, 20252,650+16.9%ir|change_in_pres_2026Q1 ↗
Q2 2025Jun 30, 20252,626+21.8%ir|change_in_pres_2026Q1 ↗
Q1 2025Mar 31, 20252,417+16.7%ir|change_in_pres_2026Q1 ↗
Q4 2024Dec 31, 20242,680+13.4%ir|change_in_pres_2026Q1 ↗
Q3 2024Sep 30, 20242,267+14.5%ir|change_in_pres_2026Q1 ↗
Q2 2024Jun 30, 20242,156+10.6%ir|change_in_pres_2026Q1 ↗
Q1 2024Mar 31, 20242,072+13.8%ir|change_in_pres_2026Q1 ↗
Q4 2023Dec 31, 20232,363–ir|change_in_pres_2026Q1 ↗
Q3 2023Sep 30, 20231,980-0.3%ir|change_in_pres_2026Q1 ↗
Q2 2023Jun 30, 20231,949+1.0%ir|change_in_pres_2026Q1 ↗
Q1 2023Mar 31, 20231,821+1.2%ir|change_in_pres_2026Q1 ↗
Q3 2022Sep 30, 20221,985–Stryker Form 10-Q — FY2023Q3 (filed 2023-11-03) ↗

Cite this data

StockData. (2026). Stryker MedSurg & Neurotechnology — U.S. Net Sales ($M), quarterly Q1 2022–Q3 2026 [Data set]. Compiled from Stryker SEC filings and investor materials. https://stockdatahq.com/stocks/syk/kpis/ms-tot-us-rev

See every metric in the Stryker KPI table. Data updated Nov 2, 2026.